Fluticasone: all 234 studies that test it

Page 1 of 3. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic RhinitisNot yet recruitingNCT07817134Phase 4
• Novel Method for Removal of Orally Deposited Inhaled Fluticasone PropionateNot yet recruitingNCT07664527Phase 4
• Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal PolypsRecruitingNCT06850805Phase 3
• Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoERecruitingNCT06705387Phase 2
• Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)Not yet recruitingNCT06234345Phase 3
• Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy VolunteersRecruitingNCT06025214Phase 1
• A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.RecruitingNCT05776927Phase 3
• Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)RecruitingNCT05275686Phase 2
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)CompletedNCT05736874Phase 3Results posted
• Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)CompletedNCT05444543Phase 4Results posted
• ACTIV-6: COVID-19 Study of Repurposed MedicationsCompletedNCT04885530Phase 3Results posted
• A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With AsthmaCompletedNCT04677959Phase 4Results posted
• Personalized Treatment Algorithms for Difficult-to-treat AsthmaCompletedNCT04179461Phase 2Results posted
• Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal PolypsCompletedNCT03960580Phase 3Results posted
• Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of BlepharitisCompletedNCT03926026Phase 2Results posted
• Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal PolypsCompletedNCT03781804Phase 3Results posted
• Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic VideoCompletedNCT03591068Phase 3Results posted
• Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder InhalerCompletedNCT02980133Phase 3Results posted
• SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet StudyCompletedNCT02778867Phase 2/3Results posted
• Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)CompletedNCT02730351Phase 4Results posted
• Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed GlucocorticoidsCompletedNCT02610816Phase 2/3Results posted
• Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic RhinitisCompletedNCT02402465Phase 4Results posted
• An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent AsthmaCompletedNCT02301975Phase 3Results posted
• Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis PatientsTerminatedNCT02246920Phase 3Results posted
• Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone PropionateCompletedNCT02232087Phase 1Results posted
• Comparison of Nasal Steroids After FESS in CRSwNPCompletedNCT02194062Not applicableResults posted
• Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent AsthmaCompletedNCT02175771Phase 3Results posted
• Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent AsthmaCompletedNCT02141854Phase 3Results posted
• Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid TreatmentCompletedNCT02141633Not applicableResults posted
• Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent AsthmaCompletedNCT02139644Phase 3Results posted
• A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese SubjectsCompletedNCT02094937Phase 3Results posted
• Step-up Yellow Zone Inhaled Corticosteroids to Prevent ExacerbationsCompletedNCT02066129Phase 3Results posted
• Use of Mobile Devices and the Internet to Streamline an Asthma Clinical TrialCompletedNCT02061280Phase 4Results posted
• Budesonide Versus Fluticasone for Treatment of Eosinophilic EsophagitisCompletedNCT02019758Phase 4Results posted
• A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic DermatitisCompletedNCT01915914Phase 4Results posted
• Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)CompletedNCT01915823Phase 3Results posted
• Dose-Response of Salmeterol in ChildrenCompletedNCT01907334Phase 4Results posted
• Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled AsthmaTerminatedNCT01881412Not applicableResults posted
• A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic PatientsCompletedNCT01836471Phase 2Results posted
• Assessment of Fluticasone Propionate on Ocular Allergy SymptomsCompletedNCT01817790Phase 3Results posted
• 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic RhinitisCompletedNCT01794741Phase 3Results posted
• Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma SubjectsCompletedNCT01772368Phase 2Results posted
• A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese SubjectsCompletedNCT01751113Phase 4Results posted
• Management of Recurrent CroupTerminatedNCT01748162Phase 3Results posted
• Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional DeviceCompletedNCT01624662Phase 3Results posted
• Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal PolypsCompletedNCT01623323Phase 3Results posted
• 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose DeviceCompletedNCT01623310Phase 3Results posted
• Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess SafetyCompletedNCT01622569Phase 3Results posted
• Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic RhinitisCompletedNCT01578278Phase 2Results posted
• A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsCompletedNCT01576718Phase 2Results posted
• A Dose-ranging Study of Fluticasone Furoate (FF)CompletedNCT01563029Phase 2Results posted
• Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung DiseaseTerminatedNCT01554488Phase 4Results posted
• Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid TreatmentCompletedNCT01537133Not applicableResults posted
• Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term GrowthCompletedNCT01520688Phase 4Results posted
• A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing SteroidsCompletedNCT01479621Phase 2Results posted
• SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.CompletedNCT01475721Phase 4Results posted
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years OldCompletedNCT01462344Phase 4Results posted
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to PlaceboCompletedNCT01439815Phase 4Results posted
• Long-acting Beta Agonist Step Down StudyCompletedNCT01437995Phase 4Results posted
• Preventative Omalizumab or Step-up Therapy for Severe Fall ExacerbationsCompletedNCT01430403Phase 4Results posted
• Intranasal SB-705498 in Allergic Rhinitis (AR) PatientsCompletedNCT01424397Phase 2Results posted
• Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic RhinitisCompletedNCT01365650Phase 1Results posted
• Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy SubjectsCompletedNCT01365611Phase 1Results posted
• Targeted Therapy of Bronchiolitis Obliterans SyndromeCompletedNCT01307462Phase 2Results posted
• Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the AirwayCompletedNCT01231230Not applicableResults posted
• Sub-Sensitivity to Long-Acting Bronchodilators (LABA)CompletedNCT01117116Not applicableResults posted
• A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary DiseaseCompletedNCT00995475Phase 4Results posted
• Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00975195Phase 4Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00883168Phase 3Results posted
• A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge ChamberCompletedNCT00848965Phase 4Results posted
• A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00784550Phase 4Results posted
• A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00740792Phase 3Results posted
• Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?CompletedNCT00716963Phase 4Results posted
• The Effects of Montelukast on Smokers With AsthmaCompletedNCT00712335Phase 4Results posted
• MethaCholine Bronchoprovocation Study (MeCIS)CompletedNCT00705341Phase 4Results posted
• Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00669617Phase 3Results posted
• Inhaled Corticosteroids Versus Observation for Patients With Decreased Lung Function StatusTerminatedNCT00656916Phase 2Results posted
• Induced Sputum Study (0000-065)CompletedNCT00623714Phase 1Results posted
• Cutivate Lotion HPA Axis Pediatric StudyCompletedNCT00546000Phase 4Results posted
• Comparator Study Evaluating Patient Preference Of FFNS vs. FPNSCompletedNCT00539006Phase 4Results posted
• Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPDCompletedNCT00530842Phase 4Results posted
• Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly GenotypesCompletedNCT00521222Not applicableResults posted
• Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNSCompletedNCT00519636Phase 4Results posted
• Study Of Fluticasone Propionate/Salmeterol In Asthmatic SubjectsCompletedNCT00517634Phase 4Results posted
• Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?TerminatedNCT00509197Not applicableResults posted
• Study Of RV-39 In Patients Who Also Have AsthmaTerminatedNCT00503009Phase 4Results posted
• SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)CompletedNCT00455923Phase 4Results posted
• A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With AsthmaCompletedNCT00452699Phase 4Results posted
• A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With AsthmaCompletedNCT00452348Phase 4Results posted
• A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With AsthmaCompletedNCT00441441Phase 3Results posted
• A Study of Flovent in Patients With Eosinophilic EsophagitisCompletedNCT00426283Phase 2Results posted
• Fluticasone Nasal Spray Patient Preference StudyCompletedNCT00398476Phase 3Results posted
• Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)CompletedNCT00395304Phase 3Results posted
• Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)TerminatedNCT00387036Phase 2Results posted
• Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled CorticosteroidsCompletedNCT00353873Phase 4Results posted
• Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)CompletedNCT00306163Phase 3Results posted
• Study Of Allergic Rhinitis In Patients Who Also Have AsthmaCompletedNCT00296491Phase 4Results posted
• Topical Steroid Treatment for Eosinophilic EsophagitisCompletedNCT00275561Phase 2Results posted
• Enhancement of in-Vitro GC Function in Patients With COPDCompletedNCT00241631Phase 2Results posted
• The Effect of Salmeterol on Eosinophil (EOS) FunctionCompletedNCT00214019Not applicableResults posted

← Fluticasone overview